Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01)

קרןNational Cancer Institute/NIH
מדינהU.S.A.
סוגResearch Grants
תאריך אחרון10/06/2020
תאריכים נוספים06/11/2020
10/06/2021
08/11/2021
פקולטהLife Sciences, Medicine
תיאור

The purpose of this grant is to support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses.  Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.  

 

Funding: no fixed limit 

Duration: 5 years

 

Research Autority due date: 10 days prior to submission 

LOI (encouraged) due date: 10.5.19, 6.10.19, 20.5.20, 6.10.20, 10.5.21, 8.10.21

Full proposal due date: 10.6.19, 6.11.19, 20.6.20, 6.11.20, 10.6.21, 8.11.21

קבצים מצורפים
קישורלאתר
עדכון אחרוןעדכון אחרון: 28/02/2019
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive